KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbbVie (ABBV) Interest Expenses (2016)

AbbVie has reported Interest Expenses over the past 5 years, most recently at $245.0 million for Q2 2016.

  • Quarterly Interest Expenses rose 42.44% to $245.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $245.0 million through Mar 2017, down 69.45% year-over-year, with the annual reading at $719.0 million for FY2015, 67.6% up from the prior year.
  • Interest Expenses was $245.0 million for Q2 2016 at AbbVie, up from $215.0 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $245.0 million in Q2 2016 and troughed at $10.0 million in Q3 2012.
  • The 5-year median for Interest Expenses is $113.0 million (2012), against an average of $125.8 million.
  • The largest YoY upside for Interest Expenses was 650.0% in 2013 against a maximum downside of 21.28% in 2013.
  • A 5-year view of Interest Expenses shows it stood at $94.0 million in 2012, then decreased by 21.28% to $74.0 million in 2013, then soared by 87.84% to $139.0 million in 2014, then skyrocketed by 49.64% to $208.0 million in 2015, then increased by 17.79% to $245.0 million in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Interest Expenses are $245.0 million (Q2 2016), $215.0 million (Q1 2016), and $208.0 million (Q4 2015).